Abstract
<h3>Watch the video or read the poster to learn about:</h3> <ul><li>The benefits of using stable cell lines to produce lentivirus</li><li>The advantages the EuLV lentiviral production system offers as compared to plasmid transfection</li><li>An example 25L-scale LVV production process in WAVE Bioreactor</li></ul><div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsights.blob.core.windows.net/uploads/2659927c4c9e47f9b3a3f2115bb4dda1.jpg" data-image="1"></div><div class="author-det"> <b>Mr Liu</b> graduated from the Hong Kong University of Science and Technology with a Master degree in Biotechnology. He previously worked in Bio-techne and InvivoGen. Mr Liu joined Eureka Bio in 2016 as COO, and he has extensive knowledge in Gene and Cell therapy industry, and is experienced in business development, project management, process development, cGMP etc. </div></div></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
